Surface Oncology Inc
NASDAQ:SURF 11:40:11 AM EDT
Earnings Announcements
Surface Oncology Inc Posts QTRLY Diluted Net Income Per Share Of $0.13
Published: 05/09/2022 13:46 GMT
Surface Oncology Inc (SURF) - Qtrly Diluted Net Income per Share of $0.13.
Surface Oncology - As of March 31, 2022, Cash, Cash Equivalents & Marketable Securities Were $150.4 Million, Versus $154.1 Million on Dec 31, 2021.
Surface Oncology - Projects Its Cash Runway Extending Into 2024.
Q1 Earnings per Share View $-0.29, Revenue View $10.5 Million -- Refinitiv Ibes Data (analyst estimates).
Further Company Coverage: .
Surface Oncology - As of March 31, 2022, Cash, Cash Equivalents & Marketable Securities Were $150.4 Million, Versus $154.1 Million on Dec 31, 2021.
Surface Oncology - Projects Its Cash Runway Extending Into 2024.
Q1 Earnings per Share View $-0.29, Revenue View $10.5 Million -- Refinitiv Ibes Data (analyst estimates).
Further Company Coverage: .
Revenue is expected to be $6.58 Million
Adjusted EPS is expected to be -$0.45
Next Quarter Revenue Guidance is expected to be $0.58 Million
Next Quarter EPS Guidance is expected to be -$0.47
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.45
Next Quarter Revenue Guidance is expected to be $0.58 Million
Next Quarter EPS Guidance is expected to be -$0.47
More details on our Analysts Page.